My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    1.

    Alzheimer's disease: new diagnostic and therapeutic tools.

    Racchi M, Uberti D, Govoni S, Memo M, Lanni C, Vasto S, Candore G, Caruso C, Romeo L, Scapagnini G.

    Immun Ageing. 2008 Aug 13;5:7.PMID: 18700965 [PubMed - in process]Related articlesFree article

    2.

    Curcumin, inflammation, ageing and age-related diseases.

    Sikora E, Scapagnini G, Barbagallo M.

    Immun Ageing. 2010 Jan 17;7(1):1.PMID: 20205886 [PubMed - in process]Related articlesFree article

    3.

    Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.

    Candore G, Balistreri CR, Grimaldi MP, Vasto S, Listì F, Chiappelli M, Licastro F, Lio D, Caruso C.

    Ann N Y Acad Sci. 2006 Nov;1089:472-86. Review.PMID: 17261790 [PubMed - indexed for MEDLINE]Related articles

    4.

    Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease.

    Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, Listì F, Vasto S, Lio D, Caruso C, Candore G.

    Curr Pharm Des. 2008;14(26):2672-7.PMID: 19006850 [PubMed - indexed for MEDLINE]Related articles

    5.

    Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type?

    Pomponi M, Di Gioia A, Bria P, Pomponi MF.

    Curr Alzheimer Res. 2008 Oct;5(5):422-31.PMID: 18855583 [PubMed - indexed for MEDLINE]Related articles

    6.

    Conformationally altered p53: a novel Alzheimer's disease marker?

    Lanni C, Racchi M, Mazzini G, Ranzenigo A, Polotti R, Sinforiani E, Olivari L, Barcikowska M, Styczynska M, Kuznicki J, Szybinska A, Govoni S, Memo M, Uberti D.

    Mol Psychiatry. 2008 Jun;13(6):641-7. Epub 2007 Aug 7.PMID: 17684496 [PubMed - indexed for MEDLINE]Related articles

    7.

    What is 'early onset dementia'?

    Miyoshi K.

    Psychogeriatrics. 2009 Jun;9(2):67-72. Review.PMID: 19604328 [PubMed - indexed for MEDLINE]Related articles

    8.

    Conformationally altered p53: a putative peripheral marker for Alzheimer's disease.

    Uberti D, Lanni C, Racchi M, Govoni S, Memo M.

    Neurodegener Dis. 2008;5(3-4):209-11. Epub 2008 Mar 6. Review.PMID: 18322392 [PubMed - indexed for MEDLINE]Related articles

    9.

    Introduction.

    Hughes A, Burns A.

    Int J Neuropsychopharmacol. 2000 Jul;3(7):1-2.PMID: 11343618 [PubMed - as supplied by publisher]Related articles

    10.

    Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

    Liu G, Men P, Perry G, Smith MA.

    J Nanoneurosci. 2009 Jun 1;1(1):42-55.PMID: 19936278 [PubMed]Related articlesFree article

    11.

    New age of neuroproteomics in Alzheimer's disease research.

    Kovacech B, Zilka N, Novak M.

    Cell Mol Neurobiol. 2009 Sep;29(6-7):799-805. Epub 2009 Feb 19. Review.PMID: 19225878 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps.

    Bartus RT, Dean RL 3rd.

    Psychopharmacology (Berl). 2009 Jan;202(1-3):15-36. Epub 2008 Nov 15. Review.PMID: 19011839 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature]

    Lagodka A, Robert P.

    Encephale. 2009 Sep;35(4):386-93. Epub 2008 Sep 23. Review. French. PMID: 19748376 [PubMed - indexed for MEDLINE]Related articles

    14.

    Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease.

    Iqbal K, Chohan MO, Grundke-Iqbal I.

    J Alzheimers Dis. 2008 Oct;15(2):339-45. Review.PMID: 18953118 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Role of biomarkers in studies of presymptomatic Alzheimer's disease.

    Morris JC, Kimberly A, Quaid K, Holtzman DM, Kantarci K, Kaye J, Reiman EM, Klunk WE, Siemers ER.

    Alzheimers Dement. 2005 Oct;1(2):145-51.PMID: 19595847 [PubMed - in process]Related articles

    16.

    Dissecting molecular mechanisms in the living brain of dementia patients.

    Barrio JR, Satyamurthy N, Huang SC, Petric A, Small GW, Kepe V.

    Acc Chem Res. 2009 Jul 21;42(7):842-50.PMID: 19281227 [PubMed - indexed for MEDLINE]Related articles

    17.

    P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients.

    Zhou X, Jia J.

    Neurosci Lett. 2010 Jan 14;468(3):320-5. Epub 2009 Nov 13.PMID: 19914341 [PubMed - in process]Related articles

    18.

    Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease.

    Orhan G, Orhan I, Subutay-Oztekin N, Ak F, Sener B.

    Recent Pat CNS Drug Discov. 2009 Jan;4(1):43-51. Review.PMID: 19149713 [PubMed - indexed for MEDLINE]Related articles

    19.

    Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

    Marlatt MW, Lucassen PJ, Perry G, Smith MA, Zhu X.

    J Alzheimers Dis. 2008 Oct;15(2):199-210. Review.PMID: 18953109 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

    Davatzikos C, Xu F, An Y, Fan Y, Resnick SM.

    Brain. 2009 Aug;132(Pt 8):2026-35. Epub 2009 May 4.PMID: 19416949 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk